Report overview
The global Eukaryotic Transcriptome Sequencing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Total RNA Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Eukaryotic Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific and Azenta, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Eukaryotic Transcriptome Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eukaryotic Transcriptome Sequencing. This report contains market size and forecasts of Eukaryotic Transcriptome Sequencing in global, including the following market information:
Global Eukaryotic Transcriptome Sequencing Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Eukaryotic Transcriptome Sequencing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eukaryotic Transcriptome Sequencing Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Eukaryotic Transcriptome Sequencing Market Segment Percentages, by Type, 2023 (%)
Total RNA
Noncoding RNA
Global Eukaryotic Transcriptome Sequencing Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Eukaryotic Transcriptome Sequencing Market Segment Percentages, by Application, 2023 (%)
Biomedical Field
Non-medical Field
Global Eukaryotic Transcriptome Sequencing Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Eukaryotic Transcriptome Sequencing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eukaryotic Transcriptome Sequencing revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Eukaryotic Transcriptome Sequencing revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Eukaryotic Transcriptome Sequencing, market overview.
Chapter 2: Global Eukaryotic Transcriptome Sequencing market size in revenue.
Chapter 3: Detailed analysis of Eukaryotic Transcriptome Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eukaryotic Transcriptome Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
